Found My Fitness

380 ‒ The seed oil debate: are they uniquely harmful relative to other dietary fats?

Guest: LaneJanuary 19, 2026

seed oils polyunsaturated fat saturated fat trans fat ldl cholesterol cardiovascular disease atherosclerosis mandelian randomization nutritional research oxidized ldl

380 ‒ The seed oil debate: are they uniquely harmful relative to other dietary fats?

Episode Summary

AI-generated · Mar 2026

AI-generated summary — may contain inaccuracies. Not a substitute for the full episode or professional advice.

In this unique episode of The Drive Podcast, host Peter Attia addresses the highly contentious "seed oil debate" – specifically, whether industrially processed seed oils are uniquely harmful relative to other dietary fats. Attia originally planned a formal debate, but when the proponent of the "seed oils are uniquely harmful" argument withdrew, he chose to "steelman" that position himself. His guest, Lane, then systematically deconstructs these arguments, providing a nuanced, evidence-based perspective on the role of polyunsaturated fats (PUFAs) in health, particularly cardiovascular disease.

👤 Who Should Listen

Anyone confused by conflicting dietary advice on seed oils, saturated fats, and heart health.
Health-conscious individuals seeking a deep, evidence-based understanding of the mechanisms behind atherosclerosis and LDL cholesterol.
Listeners interested in the process of scientific inquiry, including how biases are addressed and how different study designs (RCTs, MR) contribute to evidence.
Medical professionals or researchers looking for a comprehensive overview of the current scientific consensus and ongoing debates surrounding dietary fats.
Fans of Peter Attia's podcast who appreciate his rigorous, nuanced approach to complex health topics and his 'steelmanning' technique.

🔑 Key Takeaways

1.Peter Attia adopted a "steelmanning" approach to the seed oil debate, presenting the strongest possible arguments for the opposing viewpoint after his planned debate guest withdrew, aiming to cut through the noise for listeners.
2.Older randomized controlled trials (RCTs) like the Minnesota Heart Study and Sydney Heart Study, which showed no benefit or increased mortality with PUFA substitution, were heavily confounded by the inclusion of significant amounts of trans fats (25-40% in margarine at the time).
3.Lane highlights the Finnish Hospital Study as a well-designed crossover RCT, unconfounded by trans fats or omega-3s, which demonstrated a 41% reduction in cardiovascular disease events when saturated fat was replaced by polyunsaturated fats.
4.Mandelian randomization studies provide powerful evidence for LDL cholesterol's causal role in cardiovascular disease, showing a consistent 50-55% reduction in risk for every ~37-39 mg/dL reduction in lifelong LDL exposure, regardless of the genetic variant causing the reduction.
5.While polyunsaturated fats are more prone to oxidation than saturated fats, this process primarily occurs *inside* the arterial intima, not in the bloodstream plasma, where antioxidants are abundant.
6.PUFA-enriched LDL particles, despite individual "flammability," lead to a smaller "bonfire" of total LDL, are less prone to enzymatic modification and retention, and are less likely to aggregate within the arterial wall compared to saturated fat-enriched particles.
7.The industrial processing of seed oils, including hexane extraction and heating, introduces negligible amounts of harmful byproducts, with residual hexane levels far below levels considered toxic or capable of causing chronic harm.

💡 Key Concepts Explained

Steelmanning an Argument

Peter Attia describes this as making the best possible case for an opposing viewpoint, even if you disagree with it. He adopted this method for the episode when his planned debate guest withdrew, aiming to thoroughly examine the "anti-seed oil" stance.

Mandelian Randomization (MR)

A research method that leverages the random assignment of genetic variants at birth to create a 'lifelong randomized controlled trial.' It allows researchers to infer causal relationships between genetically determined exposures (like LDL cholesterol levels) and health outcomes (like cardiovascular disease) with fewer confounding variables than observational studies or even short-term RCTs.

Lipid Hypothesis (Atherosclerosis Progression)

This hypothesis posits that non-HDL cholesterol particles (like LDL) containing ApoB, especially those under 70 nanometers, penetrate the arterial endothelium. Once in the intima, these particles can be enzymatically modified and retained, leading to oxidation, macrophage infiltration, foam cell formation, aggregation, inflammation, and ultimately, atherosclerotic plaque development.

Converging Lines of Evidence

Lane emphasizes this framework for scientific confidence, arguing that if multiple, independent lines of evidence (e.g., mechanistic studies, observational data, randomized controlled trials, Mendelian randomization studies) all point in the same direction, our confidence in a conclusion is much stronger than relying on any single study or type of evidence.

⚡ Actionable Takeaways

→When evaluating nutritional claims, look for "converging lines of evidence" from various study types (mechanistic, observational, randomized trials, Mandelian randomization) to build greater confidence in a conclusion, as emphasized by Lane.
→Exercise caution when interpreting older dietary intervention studies, especially those involving fats, due to potential confounders like high trans fat content in early margarines, which were not understood to be harmful at the time.
→Focus on reducing overall ApoB-containing lipoprotein particles (often reflected by LDL-C), as this is a primary driver of cardiovascular disease progression, according to Mandelian randomization and statin trial data.
→Be wary of arguments that "torture the data" by selectively highlighting small, non-significant findings (e.g., the Rose Corn Oil trial) while ignoring broader trends or major confounders.
→Understand that personal beliefs can be as powerful a driver of scientific interpretation as funding bias, and actively seek out individuals who transparently acknowledge and challenge their own biases.

⏱ Timeline Breakdown

00:00Peter Attia introduces the seed oil debate and his unique approach for the episode.

01:01Attia explains his original debate series concept and why it's difficult to execute without verification.

02:03Attia reveals the planned guest for the opposing view on seed oils withdrew, leading to his "steelmanning" strategy.

04:04Lane discusses the pervasive nature of personal bias in scientific interpretation, even more so than funding.

06:06Lane shares his personal past biases towards low-carb/animal-based diets and how evidence shifted his perspective.

08:07Attia outlines the four main arguments against seed oils: RCT mortality, LDL oxidation, industrial processing, and evolutionary perspective.

11:11Discussion of the Minnesota Heart Study, its institutionalized setting, and the unexpected lack of mortality benefit despite lowered cholesterol.

14:12Lane points out the significant confounder of trans fats in margarine used in the Minnesota Heart Study (25-40% trans fats).

15:13Attia and Lane briefly define saturated, monounsaturated, polyunsaturated, and trans fats, highlighting the structural 'kink' of cis double bonds.

26:28Discussion shifts to the Sydney Heart Study, a smaller trial with high-risk MI patients, showing higher mortality in the PUFA group, again confounded by trans fats.

33:35Lane suggests the short duration of many RCTs is another confounder for observing cardiovascular disease endpoints.

34:38Lane cites meta-analyses indicating a null overall effect for PUFA vs. SFA when trans fats are included, but a benefit when excluded.

36:41Attia and Lane discuss the Rose Corn Oil trial, noting its very small sample size and statistically insignificant, wide confidence intervals for adverse outcomes.

42:48Discussion of the VA study, showing a non-significant 18% reduction in risk with PUFAs, potentially confounded by omega-3s.

44:51Lane describes the Finnish Hospital Study, a crossover trial showing a significant 41% reduction in CVD events without trans fat or omega-3 confounders.

51:59Attia poses if PUFA benefits are just saturated fat harms; Lane argues for assessing the net effect of substitution.

56:05Discussion about which meta-analyses include or exclude trans fats and omega-3s, clarifying the divergent conclusions.

59:10Lane mentions the STARS study, which looked at plaque progression rather than hard endpoints, as another relevant trial.

61:12Attia transitions to mechanistic discussions, starting with the power of Mandelian randomization studies.

62:12Lane explains Mandelian randomization as a 'lifelong randomized control trial' due to genetic assignment at birth.

63:13Attia outlines the caveats for MR studies, specifically the need for genes not to have direct impact on other outcomes (pleiotropy).

65:16Attia provides an example of MR disproving a causal link between LDL cholesterol and cancer.

67:20Lane discusses the dose-response relationship of LDL reduction, noting 50-55% risk reduction in MR studies vs. 22% in statin trials.

72:28Lane explains the difference in risk reduction between MR (lifelong exposure) and statin trials (later intervention) through an investment analogy.

80:44Attia introduces the argument that linoleic acid (from PUFAs) converts to inflammatory arachidonic acid and increases oxidative LDL.

81:45Lane begins to unpack the lipid hypothesis and the role of LDL oxidation in atherosclerosis.

85:50Lane counters that higher linoleic acid intake and tissue levels are consistently associated with *lower* CVD risk, and conversion to arachidonic acid is saturated.

87:54Lane elaborates on the lipid hypothesis, explaining the steps from ApoB particle penetration to retention, oxidation, and aggregation.

90:55Lane clarifies that significant LDL oxidation occurs primarily within the arterial intima, not in the plasma, due to antioxidant availability.

92:58Lane explains that PUFA-enriched LDLs, despite being more oxidizable, are less prone to aggregation due to increased membrane fluidity and less ApoB modification.

96:01Lane provides a 'bonfire' analogy to explain the overall lower atherogenic risk of PUFA-enriched LDLs compared to SFA-enriched LDLs.

105:12Attia raises the concern about industrial processing of seed oils, including heating and solvent extraction (e.g., hexane).

106:13Lane addresses hexane extraction, explaining its low residual levels in oils and the extremely high dosage required for any mild toxicity, dismissing it as a significant health risk.

Best of this topic

Best seed oils episodes →Best polyunsaturated fat episodes →Best saturated fat episodes →Best trans fat episodes →Best ldl cholesterol episodes →

💬 Notable Quotes

“I always am pretty vocal about my biases and I was very vocal about stating I I don't really see something here, guys. Um, but I was also clear to point out that I'm simply the judge and not the jury and ultimately the jury decides and they're going to also decide if I can be a fair judge.”
— Lane

“people think that like funding or money is by far the biggest driver of uh people essentially like not sticking with the evidence. And I would say that in some cases that's true. But I think that personal beliefs are actually just as powerful, if not more powerful.”
— Lane